Patents by Inventor LeVoy Golden Haight

LeVoy Golden Haight has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7232425
    Abstract: A medication discharge assembly useful in patient systems includes a tubular element and a stylet. In a first, closed position, the stylet is seated within the tubular element and may provide a piercing point facilitating insertion of the tubular element to a treatment site. In a second, open position, the stylet is removed from the tubular element, and the tubular element provides a travel pathway for a drug introduced to the tubular element at a proximal connection port for specific interstitial and subcutaneous diffusion and dispersion of medication along the tubular element's length near a distal discharge port through disparate perforations, which may be formed as striations of increasing length nearer the distal discharge port. The stylet in the first position may be oriented to seal this travel pathway. Depth-finding features associated with the tubular element, visually perceptible and particularly useful for placement of the assembly, may be included.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: June 19, 2007
    Assignee: Sorenson Development, Inc.
    Inventors: James LeVoy Sorenson, LeVoy Golden Haight
  • Patent number: 7228160
    Abstract: A glucose sensor assembly useful in patient systems includes an oxygen sensor from which glucose levels in the vicinity of the peritoneal cavity may be inferred. The sensor assembly may be associated with electronics, such as any or all of a DC power supply, an LED source of blue light, a photoreceptor for red light, a CPU, and transceiver, by a direct percutaneous connection. Alternatively they may be associated transdermally with the sensor and some of the electronics being located subdurally. Insulin infusion means are contemplated to respond manually or mechanically to information from the sensors through the CPU. Mechanical response may be automatic. Infusion means may be located subdurally. It is contemplated that the present invention enable revitalization or replacement of fluorescing compounds and glucose oxidase within the sensor assembly.
    Type: Grant
    Filed: November 6, 2003
    Date of Patent: June 5, 2007
    Assignee: Sorenson Medical, Inc.
    Inventors: LeVoy Golden Haight, Kevin W. Gordon, James L. Sorenson
  • Publication number: 20040152187
    Abstract: A glucose sensor assembly useful in patient systems includes an oxygen sensor from which glucose levels in the vicinity of the peritoneal cavity may be inferred. The sensor assembly may be associated with electronics, such as any or all of a DC power supply, an LED source of blue light, a photoreceptor for red light, a CPU, and transceiver, by a direct percutaneous connection. Alternatively they may be associated transdermally with the sensor and some of the electronics being located subdurally. Insulin infusion means are contemplated to respond manually or mechanically to information from the sensors through the CPU. Mechanical response may be automatic. Infusion means may be located subdurally. It is contemplated that the present invention enable revitalization or replacement of fluorescing compounds and glucose oxidase within the sensor assembly.
    Type: Application
    Filed: November 6, 2003
    Publication date: August 5, 2004
    Inventors: LeVoy Golden Haight, Kevin W. Gordon, James L. Sorenson
  • Publication number: 20020123723
    Abstract: A medication discharge assembly useful in patient systems includes a tubular element and a stylette. In a first, closed position, the stylette is seated within the tubular element and may provide a piercing point facilitating insertion of the tubular element to a treatment site. In a second, open position, the stylette is removed from the tubular element, and the tubular element provides a travel pathway for a drug introduced to the tubular element at a proximal connection port, for specific interstitial and subcutaneous diffusion and dispersion of medication along the tubular element's length near a distal discharge port through disparate perforations, which may be formed as striations of increasing length nearer the distal discharge port. The stylette in the first position maybe oriented to seal this travel pathway. Depth finding features associated with the tubular element, visually perceptible and particularly useful for placement of the assembly, may be included.
    Type: Application
    Filed: February 21, 2002
    Publication date: September 5, 2002
    Inventors: James LeVoy Sorenson, LeVoy Golden Haight